Enterotoxaemia Vaccine

ENTEROTOXAEMIA (ET) VACCINE is used for prophylactic measures to control enterotoxaemia disease, is also known as ‘pulpy kidney disease’, caused by Clostridium perfringens type D infections in sheep and goats.

COMPOSITION: ET vaccine contains formalin inactivated cultures of Clostridium perfringens type D and epsilon toxoid. The inactivated cultures along with the toxoid are further purified and concentrated before adjuvantation with aluminium hydroxide gel.

DOSAGE & ADMINISTRATION: 2 ml for sheep and goats. For subcutaneous use only. Shake well before use.

VACCINATION SCHEDULE:
Primary Vaccination: 4 months of age and above
Booster Dose: 6 months after primary vaccination
Re-Vaccination: Annual

PRECAUTIONS: Immunize only healthy animals. Malnutrition, infestation with worms, administration of immunosuppressive agents such as corticosteroids or radiotherapy will interfere with the immune response to vaccine.

POST-VACCINATION REACTIONS: Generally, there are no adverse reactions noticed. Occasionally a transient palpable swelling may occur at the site of injection, which will subside in 24-48 hours.

STORAGE & TRANSPORT: Store and transport the vaccine between 2 and 8°C until use. At no stage should the vaccine be allowed to freeze. Protect from sunlight.

SHELF LIFE: 2 years (24 months) from the date of manufacture
PRESENTATION: Multi-dose vial of 100 ml (50 doses of 2 ml each)